ARL6IP2 antibody
Principal name
ARL6IP2 antibody
Alternative names for ARL6IP2 antibody
ATL2, Atlastin-2, ARL-6-interacting protein 2, Aip-2, ADP-ribosylation factor-like protein 6-interacting protein 2
Ncbi ID
9606, NP_071769, NP_001129145.1, NP_062691.3, NM_178050, NM_019717, NM_022374, NM_001135673
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB)
Background of ARL6IP2 antibody
- Kit Component:
- - KN301747G1, Arl6ip2 gRNA vector 1 in pCas-Guide vector
- KN301747G2, Arl6ip2 gRNA vector 2 in pCas-Guide vector
- KN301747D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Abel,A., (2004) Neurogenetics 5 (4), 239-243

Western Blot analysis of ATL2 expression in transfected 293T cell line (H00064225-T01) by ATL2 MaxPab polyclonal antibody.Lane 1: ARL6IP2 transfected lysate(45.32 KDa).Lane 2: Non-transfected lysate.

Human MCF-7; WB Suggested Anti-ARL6IP2 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: MCF7 cell lysate; ARL6IP2 antibody - C-terminal region (ARP49718_P050) in Human MCF-7 cells using Western Blot
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR218465L2V | Lenti ORF particles, Atl2 (GFP-tagged) - Mouse atlastin GTPase 2 (Atl2), transcript variant 1, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,310.00
|
|
| OriGene Technologies, Inc. | ||
| MR209125L2V | Lenti ORF particles, Atl2 (GFP-tagged) - Mouse atlastin GTPase 2 (Atl2), transcript variant 2, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR218465L1V | Lenti ORF particles, Atl2 (Myc-DDK-tagged) - Mouse atlastin GTPase 2 (Atl2), transcript variant 1, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,170.00
|
|
| OriGene Technologies, Inc. | ||
| MR209125L1V | Lenti ORF particles, Atl2 (Myc-DDK-tagged) - Mouse atlastin GTPase 2 (Atl2), transcript variant 2, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||

